Biotech Series A Investors & VC Firms
1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
6 Dimensions Capital
Grand CaymanSeed–Late Stage
17 people
Synthesis Capital
LondonSeries A–Series C
17 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
GSR United Capital
BeijingSeed–Growth
APERTURE Venture Partners
New YorkSeed–Series C$1M – $5M
4 people
NOON Ventures
CopenhagenSeed–Series A$500K – $10M
17 people
Smilegate Investment
SeoulSeed–Series B$500K
15 people
Nextblue
TokyoPre-Seed–Series A$70K – $700K
4 people
BrightEdge
AtlantaPre-Seed–Late Stage
15 people
LifeSci Venture Partners
New YorkSeries A–Series C
6 people
Onsight Ventures
InnsbruckSeed–Series A$216K – $2.2M
12 people
Birchmere Ventures
PittsburghSeed–Series A$500K – $5M
5 people
Deep Ocean Capital SGR S.P.A.
RomeSeed–Series A
17 people
IKJ Capital
Palo AltoSeed–Series A
11 people
Mérieux Equity Partners
ParisSeed–Growth$3.2M – $86M
14 people
Triventures
HerzliyaSeed–Series A$1M – $3M
9 people
America's Frontier Fund
ArlingtonSeed–Growth$500K – $10M
13 people
Bioventures Investors
WestboroughSeed–Growth$15M – $100M
16 people
iGan Partners
TorontoSeed–Series A$365K – $2.2M
10 people
Expara
SingaporePre-Seed–Series A
18 people
OS Fund
Park RidgePre-Seed–Series A$1M – $2M
3 people
Quadrille Capital
ParisSeed–Late Stage
15 people
Babel Ventures
San FranciscoPre-Seed–Series A$100K – $3M
7 people
xista science ventures
KlosterneuburgPre-Seed–Series A$162K – $4.3M
11 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Biotech Investors & VC Firms (2475)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2349)Healthtech Series A Investors & VC Firms (2309)Enterprise Software Series A Investors & VC Firms (2264)
Data sourced from public filings and firms' own websites — see our methodology.






























































































